JCR Pharmaceuticals is a Japanese pharmaceutical company and CDMO founded in 1975, with nearly 50 years of experience in rare disease treatments and orphan drug production. Selected for Japan's Regenerative Medicine CDMO Subsidy Program in 2025, the company is expanding biomanufacturing infrastructure for cell, gene, and regenerative medicine therapies. JCR operates five production sites and has proprietary platforms including JUST-AAV for gene therapy and J-Brain Cargo for blood-brain barrier penetration.
regenerative medicine CDMO, rare disease therapies, AAV gene therapy (JUST-AAV platform), blood-brain barrier drug delivery (J-Brain Cargo), lysosomal storage disorders
1 site worldwide
Involvement in 2 clinical trials
No reviews available yet.
No documents available.